N,N'-Bis-[3-(2,2,2-trifluoro-ethylamino)-propyl]-butane-1,4-diamine

ID: ALA306840

Chembl Id: CHEMBL306840

PubChem CID: 9998968

Max Phase: Preclinical

Molecular Formula: C14H28F6N4

Molecular Weight: 366.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  FC(F)(F)CNCCCNCCCCNCCCNCC(F)(F)F

Standard InChI:  InChI=1S/C14H28F6N4/c15-13(16,17)11-23-9-3-7-21-5-1-2-6-22-8-4-10-24-12-14(18,19)20/h21-24H,1-12H2

Standard InChI Key:  BWFFJKUUEUOBNI-UHFFFAOYSA-N

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Odc1 Ornithine decarboxylase (263 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sat2 Spermidine/spermine N(1)-acetyltransferase (SAT) (56 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 366.39Molecular Weight (Monoisotopic): 366.2218AlogP: 2.03#Rotatable Bonds: 15
Polar Surface Area: 48.12Molecular Species: BASEHBA: 4HBD: 4
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.68CX LogP: 1.32CX LogD: -4.26
Aromatic Rings: Heavy Atoms: 24QED Weighted: 0.26Np Likeness Score: -0.53

References

1. Bergeron RJ, McManis JS, Weimar WR, Schreier KM, Gao F, Wu Q, Ortiz-Ocasio J, Luchetta GR, Porter C, Vinson JR..  (1995)  The role of charge in polyamine analogue recognition.,  38  (13): [PMID:7608892] [10.1021/jm00013a003]
2. Bergeron RJ, Wiegand J, McManis JS, Weimar WR, Smith RE, Algee SE, Fannin TL, Slusher MA, Snyder PS..  (2001)  Polyamine analogue antidiarrheals: a structure-activity study.,  44  (2): [PMID:11170633] [10.1021/jm000277+]
3. Bergeron RJ, Yao GW, Yao H, Weimar WR, Sninsky CA, Raisler B, Feng Y, Wu Q, Gao F..  (1996)  Metabolically programmed polyamine analogue antidiarrheals.,  39  (13): [PMID:8691443] [10.1021/jm950827h]
4. Bergeron RJ, Weimar WR, Wu Q, Feng Y, McManis JS..  (1996)  Polyamine analogue regulation of NMDA MK-801 binding: a structure-activity study.,  39  (26): [PMID:8978854] [10.1021/jm960545x]
5. Bergeron RJ, Huang G, McManis JS, Yao H, Nguyen JN..  (2005)  Synthesis and biological evaluation of aminopolyamines.,  48  (9): [PMID:15857111] [10.1021/jm050024m]
6. Bergeron RJ, Bharti N, Wiegand J, McManis JS, Yao H, Prokai L..  (2005)  Polyamine-vectored iron chelators: the role of charge.,  48  (12): [PMID:15943485] [10.1021/jm048974f]

Source